UK markets closed

OBI Pharma, Inc. (4174.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
59.00-0.80 (-1.34%)
At close: 01:30PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,594,892
-1,046,475
-1,613,916
-1,530,687
-1,377,935
-
Depreciation & amortisation
231,998
248,953
246,610
216,275
231,839
-
Stock-based compensation
140,684
119,197
148,995
54,017
76,821
-
Change in working capital
13,147
-63,536
-92,372
376,714
-388,142
-
Inventory
-16,669
-3,959
-9,741
-2,204
-3,158
-
Other working capital
-1,851,394
-1,761,141
-1,920,259
-1,309,662
-1,795,086
-
Other non-cash items
-24,181
-83,019
-45,941
-2,660
-39,005
-
Net cash provided by operating activities
-1,476,239
-1,652,980
-1,619,702
-1,064,479
-1,609,441
-
Cash flows from investing activities
Investments in property, plant and equipment
-375,155
-108,161
-300,557
-245,183
-185,645
-
Acquisitions, net
0
-
0
472,651
0
0
Purchases of investments
-2,935,733
-3,296,633
-30,710
-140,000
0
-
Sales/maturities of investments
1,742,253
983,035
140,000
0
-
0
Other investing activities
14,047
-13,168
21,327
-4,790
-10,258
-
Net cash used for investing activities
-422,858
-2,795,361
-169,886
82,678
-195,903
-
Net change in cash
1,915,854
-3,841,832
2,228,923
-826,116
-1,521,713
-
Cash at beginning of period
3,159,213
4,741,109
2,512,186
3,338,302
4,860,015
-
Cash at end of period
5,064,307
899,277
4,741,109
2,512,186
3,338,302
-
Free cash flow
Operating cash flow
-1,476,239
-1,652,980
-1,619,702
-1,064,479
-1,609,441
-
Capital expenditure
-375,155
-108,161
-300,557
-245,183
-185,645
-
Free cash flow
-1,851,394
-1,761,141
-1,920,259
-1,309,662
-1,795,086
-